Insulin and its preparations MCQs With Answer
Insulin therapy is central to diabetes care, and mastery of insulin preparations is crucial for B. Pharm students. This concise guide covers insulin classification, insulin analogs (lispro, aspart, glulisine, glargine, detemir, degludec), pharmacokinetics and pharmacodynamics (onset, peak, duration), formulations (regular, NPH, U-100, U-500), routes and devices (subcutaneous, IV, pumps), storage and stability, mixing rules, dosing strategies such as basal-bolus, and adverse effects including hypoglycemia and lipodystrophy. Topics also include immunogenicity, biosimilars, insulin assays, patient counseling, and emergency management to build practical pharmacy competence.
‘Now let’s test your knowledge with 30 MCQs on this topic.’
Q1. Which parameters form the basis for classifying insulin preparations?
- Manufacturer and brand name
- Onset, peak and duration of action
- Route of administration only
- Concentration (units/mL) only
Correct Answer: Onset, peak and duration of action
Q2. Which of the following is a rapid-acting insulin analog?
- Insulin lispro
- Regular (soluble) insulin
- NPH (isophane) insulin
- Insulin glargine
Correct Answer: Insulin lispro
Q3. Typical onset of action for insulin lispro is approximately:
- 5 minutes
- 15 minutes
- 60 minutes
- 3 hours
Correct Answer: 15 minutes
Q4. The peak action time of NPH (intermediate-acting) insulin is usually around:
- 30–60 minutes
- 1–2 hours
- 4–10 hours
- 24 hours
Correct Answer: 4–10 hours
Q5. Which insulin provides a relatively flat, long-acting basal profile and should not be mixed with other insulins?
- Insulin aspart
- Regular insulin
- Insulin glargine
- NPH insulin
Correct Answer: Insulin glargine
Q6. Which insulin analog is classified as ultra-long acting with very prolonged duration (>42 hours) suitable for once-daily dosing?
- Insulin detemir
- Insulin degludec
- Insulin lispro
- Regular insulin
Correct Answer: Insulin degludec
Q7. Which insulin formulation is suitable for intravenous infusion in emergencies like DKA?
- Insulin NPH suspension
- Insulin glargine solution
- Regular (soluble) human insulin
- Insulin detemir suspension
Correct Answer: Regular (soluble) human insulin
Q8. What does a U-500 insulin formulation indicate?
- 500 units per vial (no volume specified)
- 500 units per mL (concentrated insulin)
- 500 international units per injection recommended
- Use only for pediatric patients
Correct Answer: 500 units per mL (concentrated insulin)
Q9. Unopened insulin vials should be stored at which temperature range to maintain stability?
- Room temperature (20–25°C)
- Freezer (<0°C)
- Refrigerator (2–8°C)
- Any temperature is acceptable
Correct Answer: Refrigerator (2–8°C)
Q10. After opening, many insulin vials/cartridges can be used at room temperature for approximately:
- 7 days
- 14 days
- 28 days
- 6 months
Correct Answer: 28 days
Q11. Which insulin preparation should not be mixed in the same syringe with other insulins due to pH incompatibility?
- Regular insulin
- Insulin NPH
- Insulin glargine
- Insulin lispro
Correct Answer: Insulin glargine
Q12. When mixing short-acting insulin with NPH in one syringe, which technique is recommended?
- Draw cloudy (NPH) then clear (regular) — cloudy before clear
- Draw clear (regular) then cloudy (NPH) — clear before cloudy
- Mix vials vigorously before drawing
- Always mix glargine first
Correct Answer: Draw clear (regular) then cloudy (NPH) — clear before cloudy
Q13. First-line immediate treatment for a conscious patient experiencing symptomatic hypoglycemia is:
- Intravenous 50% dextrose (IV bolus)
- Intramuscular glucagon only
- Oral administration of 15–20 g fast-acting carbohydrate (glucose)
- Wait and observe for spontaneous recovery
Correct Answer: Oral administration of 15–20 g fast-acting carbohydrate (glucose)
Q14. The most frequent adverse effect associated with insulin therapy is:
- Hepatotoxicity
- Hypoglycemia
- Severe hypertension
- Renal failure
Correct Answer: Hypoglycemia
Q15. Best practice to prevent lipodystrophy at injection sites is:
- Use the same injection spot every time
- Rotate injection sites systematically
- Always inject into scar tissue
- Change insulin brand weekly
Correct Answer: Rotate injection sites systematically
Q16. Rapid-acting analogs achieve faster absorption than regular insulin mainly because:
- They contain added enzymes to digest insulin
- Amino acid substitutions reduce hexamer formation
- They are given intramuscularly only
- They are more concentrated (U-500)
Correct Answer: Amino acid substitutions reduce hexamer formation
Q17. Most clinical insulin preparations today are produced by which method?
- Purified bovine pancreas extracts
- Chemical synthesis from amino acids
- Recombinant DNA technology (human insulin produced in microbes)
- Extraction from porcine pancreas only
Correct Answer: Recombinant DNA technology (human insulin produced in microbes)
Q18. Basal-bolus insulin therapy typically combines which types of insulin?
- Two intermediate-acting insulins only
- Long-acting basal insulin plus rapid-acting bolus insulin
- Only ultra-long acting insulins
- Only pre-mixed insulin twice daily
Correct Answer: Long-acting basal insulin plus rapid-acting bolus insulin
Q19. Insulin pumps (continuous subcutaneous insulin infusion) most commonly use which insulin type?
- NPH suspension
- Regular human insulin
- Rapid-acting insulin analogs
- Insulin glargine solution
Correct Answer: Rapid-acting insulin analogs
Q20. Which insulin has an onset of ~30 minutes and a peak at about 2–4 hours, often used before meals?
- Insulin lispro
- Regular (soluble) insulin
- Insulin glargine
- Insulin detemir
Correct Answer: Regular (soluble) insulin
Q21. NPH insulin is an intermediate-acting preparation formed by complexing insulin with:
- Protamine
- Albumin
- Fatty acids
- Zinc-free buffer
Correct Answer: Protamine
Q22. Historically, which insulin source was associated with higher immunogenicity compared to recombinant human insulin?
- Recombinant human insulin
- Pork (porcine) and bovine animal-derived insulin
- Synthetic peptide insulin
- Plant-derived insulin analogs
Correct Answer: Pork (porcine) and bovine animal-derived insulin
Q23. Insulin exerts its cellular effects primarily by binding to which receptor type?
- G-protein coupled receptor
- Tyrosine kinase receptor
- Nuclear steroid receptor
- Ion channel receptor
Correct Answer: Tyrosine kinase receptor
Q24. A common metabolic consequence of insulin therapy that pharmacists should counsel about is:
- Weight loss
- Weight gain
- Hyperthyroidism
- Ototoxicity
Correct Answer: Weight gain
Q25. Which injection site generally provides the fastest absorption of subcutaneous insulin?
- Thigh
- Upper arm
- Abdomen
- Buttock
Correct Answer: Abdomen
Q26. In diabetic ketoacidosis (DKA), initial insulin management typically involves:
- Subcutaneous NPH every 12 hours
- Continuous IV infusion of regular insulin
- Single IM injection of glargine
- No insulin until potassium is normalized
Correct Answer: Continuous IV infusion of regular insulin
Q27. Insulin glargine is formulated at acidic pH to improve solubility; as a result, when injected it forms microprecipitates that slowly release insulin. This formulation property explains why it:
- Can be mixed safely with NPH
- Should not be mixed with other insulins in the same syringe
- Is ideal for IV use
- Has a very rapid onset
Correct Answer: Should not be mixed with other insulins in the same syringe
Q28. Which long-acting insulin analog uses fatty-acid acylation to bind albumin and prolong duration?
- Insulin aspart
- Insulin detemir
- Insulin lispro
- Regular insulin
Correct Answer: Insulin detemir
Q29. A concentration labeled U-100 on an insulin vial means:
- 100 international units per vial
- 100 units per mL
- 100 mg per mL
- Use by 100 days from opening
Correct Answer: 100 units per mL
Q30. Which laboratory test best reflects average glycemic control over the preceding 2–3 months and is used to monitor insulin therapy effectiveness?
- Fasting plasma insulin level
- Plasma C-peptide
- HbA1c (glycated hemoglobin)
- Random glucose at one visit
Correct Answer: HbA1c (glycated hemoglobin)

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com